ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00540358
Recruitment Status : Completed
First Posted : October 8, 2007
Last Update Posted : December 28, 2012
Sponsor:
Collaborator:
BiPar Sciences
Information provided by (Responsible Party):
Sanofi

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2009
  Actual Study Completion Date : June 2010
  Certification/Extension First Submitted : July 21, 2011